113 related articles for article (PubMed ID: 32538588)
1. DERL3 suppresses colorectal cancer metastasis through negatively regulating MYCN level.
Yu F; Mou B; Sheng J; Liu J; Qin X; Yu J
Minerva Med; 2023 Jun; 114(3):316-322. PubMed ID: 32538588
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-802 inhibits the metastasis of colorectal cancer by targeting FOXE1.
Zhang Y; Ma LN; Xie Y
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1778-1785. PubMed ID: 32141546
[TBL] [Abstract][Full Text] [Related]
3. CircRIP2 aggravates the deterioration of colorectal carcinoma by negatively regulating CBFB.
Hou M; Zhang LJ; Liu J; Hu HX; Zhao YL
Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3514-3521. PubMed ID: 35647832
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
[TBL] [Abstract][Full Text] [Related]
5. MiR-548b suppresses proliferative capacity of colorectal cancer by binding WNT2.
Xu Y; Zhong YD; Zhao XX
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10535-10541. PubMed ID: 33155209
[TBL] [Abstract][Full Text] [Related]
6. Circ_0001982 accelerates the progression of colorectal cancer via sponging microRNA-144.
Deng Q; Wang CJ; Hao R; Yang QY
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1755-1762. PubMed ID: 32141543
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG3 is responsible for the deterioration of colorectal carcinoma through regulating the miR-370-5p/EZH1 axis.
Zhang Y; Li L; Lu KX; Yu LB; Meng J; Liu CY
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):6131-6137. PubMed ID: 34661273
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
10. HMGN5 promotes invasion and migration of colorectal cancer through activating FGF/FGFR pathway.
Zhu GJ; Liu F; Xu YG; Zhao CX; Zhao JG; Sun C
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1330-1338. PubMed ID: 33629303
[TBL] [Abstract][Full Text] [Related]
11. TCF19 aggravates the malignant progression of colorectal cancer by negatively regulating WWC1.
Du WB; Huang Z; Luo L; Tong SP; Li HQ; Li X; Tong JH; Yao YL; Zhang WB; Meng Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):655-663. PubMed ID: 32016966
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1.
Zhou M; Bian Z; Liu B; Zhang Y; Cao Y; Cui K; Sun S; Li J; Zhang J; Wang X; Li C; Yao S; Yin Y; Fei B; Huang Z
Cancer Med; 2021 Apr; 10(7):2470-2481. PubMed ID: 33686713
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.
Li C; Zhou H
Cancer Med; 2020 Sep; 9(18):6710-6725. PubMed ID: 32706154
[TBL] [Abstract][Full Text] [Related]
14. LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis.
Shao HJ; Li Q; Shi T; Zhang GZ; Shao F
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3749-3759. PubMed ID: 31115001
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MORT negatively regulates FGF1 to suppress malignant progression of breast cancer.
Yang Q; Yang D; Zhu HB; Li P; Wu XP; Tan YR
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6179-6186. PubMed ID: 34730198
[TBL] [Abstract][Full Text] [Related]
16. TPM4 aggravates the malignant progression of hepatocellular carcinoma through negatively regulating SUSD2.
Sheng ZG; Chen MH
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4756-4765. PubMed ID: 32432739
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
18. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
19. LPAR5 stimulates the malignant progression of non-small-cell lung carcinoma by upregulating MLLT11.
Zhang HP; Chen QK; Xu JF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8902-8910. PubMed ID: 32964980
[TBL] [Abstract][Full Text] [Related]
20. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
